Target Healthcare REIT (LON:THRL) Stock Keeps “Buy” Rating at Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating restated by equities research analysts at Jefferies Financial Group in a research note issued to investors on Thursday, Digital Look reports. They currently have a GBX 124 price target on the stock. Jefferies Financial Group’s price target points to a potential upside of 8.01% from the company’s current price.

Target Healthcare REIT Stock Up 1.4%

Shares of LON:THRL opened at GBX 114.80 on Thursday. The stock has a market cap of £712.03 million, a PE ratio of 8.62, a PEG ratio of 1.48 and a beta of 0.71. The company’s fifty day moving average is GBX 111.89 and its 200 day moving average is GBX 109.17. Target Healthcare REIT has a 52 week low of GBX 92 and a 52 week high of GBX 117.

Target Healthcare REIT (LON:THRL) last posted its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. Sell-side analysts anticipate that Target Healthcare REIT will post 6.22 EPS for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.